Brandi Livingston
Overview
Explore the profile of Brandi Livingston including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
375
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kirkpatrick Roubidoux E, Meliopoulos V, Livingston B, Brigleb P, Schultz-Cherry S
J Virol
. 2025 Jan;
:e0192724.
PMID: 39887248
No abstract available.
2.
Meliopoulos V, Cherry S, Smith M, Sharp B, Brigleb P, Roubidoux E, et al.
bioRxiv
. 2025 Jan;
PMID: 39829753
Zoonotic transmission of avian influenza viruses into mammals is relatively rare due to anatomical differences in the respiratory tract between species. Recently, clade 2.3.4.4b highly pathogenic H5N1 avian influenza viruses...
3.
Kirkpatrick Roubidoux E, Meliopoulos V, Livingston B, Brigleb P, Schultz-Cherry S
bioRxiv
. 2024 Nov;
PMID: 39554179
The ongoing outbreak of highly pathogenic avian influenza (HPAI) H5N1 of the clade 2.3.4.4b in dairy cows has led to numerous questions including how the virus transmits amongst cattle given...
4.
Brigleb P, Sharp B, Kirkpatrick Roubidoux E, Meliopoulos V, Tan S, Livingston B, et al.
bioRxiv
. 2024 Nov;
PMID: 39484458
The most recent outbreak of highly pathogenic avian H5 influenza (HPAI) virus in cattle is now widespread across the U.S. with spillover events happening to other mammals, including humans. Several...
5.
Wiggins K, Winston S, Reeves I, Gaevert J, Spence Y, Brimble M, et al.
J Virol
. 2024 Jul;
98(8):e0078124.
PMID: 39078191
Importance: Developing an improved seasonal influenza vaccine remains an ambitious goal of researchers and clinicians alike. With influenza routinely causing severe epidemics with the potential to rise to pandemic levels,...
6.
Shi H, Zhang X, Ge P, Meliopoulos V, Freiden P, Livingston B, et al.
Hum Vaccin Immunother
. 2024 Jun;
20(1):2356269.
PMID: 38826029
The influenza viruses cause seasonal respiratory illness that affect millions of people globally every year. Prophylactic vaccines are the recommended method to prevent the breakout of influenza epidemics. One of...
7.
Meliopoulos V, Honce R, Livingston B, Hargest V, Freiden P, Lazure L, et al.
Sci Adv
. 2024 May;
10(19):eadk9137.
PMID: 38728395
Obesity, and the associated metabolic syndrome, is a risk factor for increased disease severity with a variety of infectious agents, including influenza virus. Yet, the mechanisms are only partially understood....
8.
Honce R, Vazquez-Pagan A, Livingston B, Mandarano A, Wilander B, Cherry S, et al.
Nat Microbiol
. 2024 Apr;
9(6):1593-1606.
PMID: 38637722
Metabolic disease is epidemiologically linked to severe complications upon influenza virus infection, thus vaccination is a priority in this high-risk population. Yet, vaccine responses are less effective in these same...
9.
Gautam A, Boyd D, Nikhar S, Zhang T, Siokas I, Van de Velde L, et al.
Nature
. 2024 Apr;
628(8009):835-843.
PMID: 38600381
Severe influenza A virus (IAV) infections can result in hyper-inflammation, lung injury and acute respiratory distress syndrome (ARDS), for which there are no effective pharmacological therapies. Necroptosis is an attractive...
10.
Vazquez-Pagan A, Kirkpatrick Roubidoux E, Cherry S, Livingston B, Bub T, Lazure L, et al.
bioRxiv
. 2023 Nov;
PMID: 37961247
Pregnant women and infants are considered high-risk groups for increased influenza disease severity. While influenza virus vaccines are recommended during pregnancy, infants cannot be vaccinated until at least six months...